ProcEurope Customers

A preclinical-stage biotechnology company focused on developing curative gene therapies for cardiovascular diseases using specific adeno-associated viral vectors.

A clinical-stage biopharmaceutical company leading in precision medicine to diagnose, treat, and prevent neurodegenerative diseases, including Alzheimer's and Parkinson's.

A biotech startup developing an orally administered, enzyme-based dietary supplement designed to alleviate alcohol intolerance by breaking down acetaldehyde in the stomach.

A Contract Research Organization (CRO) specializing in enzyme research and development, blending wet lab expertise with advanced artificial intelligence to accelerate enzyme innovation.

A medical technology company developing modular centrifugal spin devices to streamline, standardize, and automate laboratory workflows, particularly for proteomics sample preparation.

A high-tech startup offering microscale Nuclear Magnetic Resonance (µNMR) solutions, enabling non-invasive chemical analysis for single human embryos during IVF.

A clinical-stage biopharmaceutical company leveraging a systematic discovery platform to engineer precision T-cell receptor (TCR-T) immunotherapies for hard-to-treat solid tumors. 

 A pre-clinical stage company developing first-in-class therapies based on aquaporin-9 inhibitors for the treatment of metabolic and systemic inflammatory diseases. 

An animal-health biotech company generating novel, precision-targeted parasite treatments that selectively inhibit cell division in parasites while sparing the host. 

A biotech spin-off developing an antibody-based bispecific T-cell engager for safer, chemotherapy-free precision conditioning before hematopoietic stem cell transplantation. 

A science-driven, specialised bioanalytical contract research organisation (CRO) dedicated to large molecule bioanalysis, supporting all phases of development for immune-mediated diseases and disorders. 

A clinical-stage biopharmaceutical company focused on the discovery and development of innovative, antibody-based therapies for the treatment of haematological cancers and solid tumours. 

A research-driven pharmaceutical company specialising in the development, regulatory approval, and manufacturing of allogeneic, stem cell-based medicines (like MesemCart) for treating orthopaedic conditions and cartilage damage. 

A global supplier and contract manufacturing organisation (CMO) providing critical raw materials, complex chemicals, peptides, and end-to-end manufacturing services to the life sciences and pharmaceutical industries. 

A biotech startup that develops revolutionary bionic bioreactor systems for scalable, stress-free cellular biomanufacturing. Their technology enables bubble-free gas exchange without foaming to optimize cell therapies and synthetic biologics. 

A life sciences company developing innovative bioproduction solutions. Their C-Netics technology enables real-time, non-destructive monitoring of cell viability and density inside bioreactors to maximise process efficiency. 

A deep-tech spin-off offering a high-performance screening, protein, and structural biology platform. They provide rapid access to high-fidelity chemical matter to accelerate small molecule drug discovery for pharmaceutical companies. 

A private, non-profit Swiss research and technology organisation (RTO) and innovation accelerator that transfers advanced technologies from fundamental research to industry in the domains of precision manufacturing, digitalization, and sustainable energy. 

A clinical-stage biotechnology company focusing on regenerative medicine. They bioengineer personalised human skin grafts, such as denovoSkin™, to treat severe skin defects and burns safely and with minimal scarring. 

A synthetic biology enabler specialising in advanced single-cell manipulation technologies. Using their FluidFM platform, they bridge the gap between genetic design and the manufacturing of high-precision, gene-engineered mammalian cell lines. 

A next-generation biotech company that transforms protein R&D by combining automated wet-lab data generation with machine learning to accelerate single-domain antibody discovery and optimisation. 

A leading manufacturer of high-quality dental materials providing innovative solutions for dental professionals, including composite systems, preventative treatments, and complete 3D printing workflows. 

A biotechnology company pioneering targeted protein degradation (TPD) by harnessing the lysosome's natural machinery to develop oral, small-molecule degraders of extracellular disease-causing proteins. 

An independent research institution and accredited testing laboratory specialising in applied materials research, functional polymer development, coated textiles, and leather technologies. 

An innovation-driven life science company redefining disease treatment by providing high-resolution 3D bioprinting platforms and developing next-generation tissue-based therapies for regenerative medicine. 

A biotechnology company specializing in the efficient and scalable production of complex, toxic, or cost-intensive recombinant proteins utilising alternative plant- and insect-based expression platforms. 

A provider of specialized molecular diagnostics, microbiome analysis, next-generation sequencing (NGS), and bioinformatics to detect complex genetic alterations. 

A biotechnology company developing novel treatments for neurological and psychiatric disorders by targeting glial cells (astrocytes) to restore and enhance brain energy metabolism.